Find your path to Olaf
298 people in our graph share verified history with Olaf — schools, employers, funds. One of them is your warm intro.
About
Olaf Christensen is Chief Medical Officer at Orum Therapeutics, with 14 years of pharmaceutical industry experience in the clinical development of oncology compounds and more than five years of clinical oncology experience treating patients with solid tumors, leukemia, and lymphomas. He has served as program leader for gastric cancer, prostate cancer, pediatric development, and the ipilimumab Phase II-III program, and as global early clinical development project leader overseeing study teams across North America, Europe, and Asia. His work spans First in Patient, Proof of Concept, and Phase I studies, IND and IMPD preparation, translational medicine, and interactions with health authorities in the US and Europe.
CMO at Orum Therapeutics Venture Capital
Intro paths
In turn, Olaf can intro founders to Orum Therapeutics Venture Capital's investors below.
Orum Therapeutics Venture Capital's investors · 5
Co-founders at Orum Therapeutics Venture Capital
Experience
- Orum TherapeuticsChief Medical Officercurrent2021 — presentCambridge, Massachusetts, United States
- Orum TherapeuticsChief Medical Officercurrent2021 — presentCambridge, Massachusetts, United States
- EMD Serono, Inc.Vice President2018 — 2021Billerica Massachusetts
- EMD Serono, Inc.Executive Medical Director2015 — 2018Billerica Massachusetts
- Bristol-Myers Squibb, Princeton, New JerseyGroup Director2011 — 2015Princeton, New Jersey
- Bayer PharmaceuticalsDeputy Director of Oncology2004 — 2011
- University of Heidelbergattending physician, Clinic for Medical Oncology1999 — 2004
- University of CologneArzt im Praktikum1997 — 1999
Skills & more
From Olaf's professional profile.
Frequently asked questions
- Who is Olaf Christensen?
- Olaf Christensen is Chief Medical Officer at Orum Therapeutics, with 14 years of pharmaceutical industry experience in the clinical development of oncology compounds and more than five years of clinical oncology experience treating patients with solid tumors, leukemia, and lymphomas. He has served as program leader for gastric cancer, prostate cancer, pediatric development, and the ipilimumab Phase II-III program, and as global early clinical development project leader overseeing study teams across North America, Europe, and Asia. His work spans First in Patient, Proof of Concept, and Phase I studies, IND and IMPD preparation, translational medicine, and interactions with health authorities in the US and Europe.
- Where does Olaf Christensen work?
- Olaf Christensen is CMO at Orum Therapeutics Venture Capital.
- Where did Olaf Christensen go to school?
- Olaf Christensen studied at University of Cologne (MD, medicine).
Same school
Also attended University of Cologne119
+ 113 more
Shared employers
Also worked at Orum Therapeutics2
Also worked at EMD Serono, Inc.31
+ 25 more
Also worked at Bristol-Myers Squibb, Princeton, New Jersey158
+ 152 more
Also worked at Bayer Pharmaceuticals149
+ 143 more